July 8, 2020 / 7:11 PM / in a month

BRIEF-Gilead Sciences Announces Initiation Of Phase 1A Clinical Study To Evaluate Investigational, Inhaled Solution Of Remdesivir In Healthy Volunteers

July 8 (Reuters) - Gilead Sciences Inc:

* GILEAD SCIENCES INC - STATEMENT ON INITIATION OF CLINICAL TESTING OF AN INHALED SOLUTION OF REMDESIVIR FOR POTENTIAL OUTPATIENT TREATMENT OF COVID-19

* GILEAD SCIENCES STATEMENT ON THE INITIATION OF CLINICAL TESTING OF AN INHALED SOLUTION OF REMDESIVIR FOR POTENTIAL OUTPATIENT TREATMENT OF COVID-19

* GILEAD SCIENCES INC - RANDOMIZED, PLACEBO-CONTROLLED TRIAL WILL ENROLL ABOUT 60 HEALTHY INDIVIDUALS AGED 18-45 IN US.

* GILEAD SCIENCES - ANNOUNCE INITIATION OF A PHASE 1A CLINICAL STUDY TO EVALUATE INVESTIGATIONAL, INHALED SOLUTION OF REMDESIVIR IN HEALTHY VOLUNTEERS

* GILEAD SCIENCES - ADDITIONAL CLINICAL TRIALS EVALUATING REMDESIVIR WITH ANTI-INFLAMMATORY MEDICINES, IN VULNERABLE PATIENTS, OUTPATIENT SETTINGS ONGOING/PLANNED TO INITIATE IN NEAR FUTURE Source text : [bit.ly/3f6SVsR] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below